2016
Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study
Helou E, Shenoi S, Kyriakides T, Landry ML, Kozal M, Barakat LA. Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study. Journal Of The International Association Of Providers Of AIDS Care (JIAPAC) 2016, 16: 261-266. PMID: 27903948, PMCID: PMC5423832, DOI: 10.1177/2325957416680028.Peer-Reviewed Original ResearchConceptsVirologic failureViral load levelsPill burdenAlcohol useHuman immunodeficiency virus (HIV) careLow-level HIV viremiaUndetectable viral load levelsAntiretroviral regimen changesAntiretroviral therapy changesExperienced virologic failureLow-level viremiaIntravenous drug useSubset of patientsFrequent clinic visitsPoor clinical outcomePossible risk factorsHepatitis C virusHIV viremiaMore comorbiditiesNonfailure groupVirologic suppressionVirological failureCD4 countConsecutive chartsClinic visits
2009
WU Polyomavirus in Patients Infected with HIV or Hepatitis C Virus, Connecticut, USA, 2007 - Volume 15, Number 7—July 2009 - Emerging Infectious Diseases journal - CDC
Miller MA, Weibel C, Ferguson D, Landry ML, Kahn JS. WU Polyomavirus in Patients Infected with HIV or Hepatitis C Virus, Connecticut, USA, 2007 - Volume 15, Number 7—July 2009 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2009, 15: 1095-1097. PMID: 19624928, PMCID: PMC2744261, DOI: 10.3201/eid1507.090150.Peer-Reviewed Original Research
2001
Use of Plastic Vacutainer Tubes for Quantification of Human Immunodeficiency Virus Type 1 in Blood Specimens
Landry M, Garner R, Ferguson D. Use of Plastic Vacutainer Tubes for Quantification of Human Immunodeficiency Virus Type 1 in Blood Specimens. Journal Of Clinical Microbiology 2001, 39: 354-356. PMID: 11136799, PMCID: PMC87730, DOI: 10.1128/jcm.39.1.354-356.2001.Peer-Reviewed Original Research
2000
A Multisite Trial Comparing Two Cytomegalovirus (CMV) pp65 Antigenemia Test Kits, Biotest CMV Brite and Bartels/Argene CMV Antigenemia
St. George K, Boyd M, Lipson S, Ferguson D, Cartmell G, Falk L, Rinaldo C, Landry M. A Multisite Trial Comparing Two Cytomegalovirus (CMV) pp65 Antigenemia Test Kits, Biotest CMV Brite and Bartels/Argene CMV Antigenemia. Journal Of Clinical Microbiology 2000, 38: 1430-1433. PMID: 10747120, PMCID: PMC86458, DOI: 10.1128/jcm.38.4.1430-1433.2000.Peer-Reviewed Original ResearchConceptsPp65 antigenemiaTransplant recipientsHuman immunodeficiency virus-positive patientsImmunodeficiency virus-positive patientsBone marrow transplant recipientsCMV pp65 antigenemiaOrgan transplant recipientsVirus-positive patientsMarrow transplant recipientsPositive cell countsPeripheral blood leukocytesNegative predictive valueCMV antigenemiaBlood leukocytesAntigenemiaBlood specimensPredictive valueCell countMultisite trialCytomegalovirusStatistical differenceTotalTest kitRecipientsKit
1996
Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease.
Wetherill PE, Landry ML, Alcabes P, Friedland G. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1996, 12: 33-7. PMID: 8624758, DOI: 10.1097/00042560-199605010-00005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAntibodies, MonoclonalAntigens, ViralCross-Sectional StudiesCytomegalovirusCytomegalovirus InfectionsCytomegalovirus RetinitisFemaleFluorescent Antibody TechniqueHIV SeropositivityHIV-1HumansLeukocytesMaleMiddle AgedPredictive Value of TestsRetrospective StudiesViral Matrix ProteinsViremiaConceptsCMV antigenemia testCMV diseaseAntigenemia testCMV antigenemiaHIV diseaseCytomegalovirus antigenemia testPositive CMV antigenemiaLife-threatening infectionsDiagnostic techniquesAntigenemia levelsAntigenemia resultsCMV retinitisCytomegalovirus infectionCMV cultureClinical evidenceOphthalmologic examPatientsDiseaseRapid diagnosisAntigenemiaInfectionDiagnosisQuantitative diagnostic techniqueRetinitisHIVEvaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence
Landry ML, Ferguson D, Stevens-Ayers T, de Jonge MW, Boeckh M. Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence. Journal Of Clinical Microbiology 1996, 34: 1337-1339. PMID: 8727936, PMCID: PMC229015, DOI: 10.1128/jcm.34.5.1337-1339.1996.Peer-Reviewed Original Research
1995
Fatal enterovirus type 71 infection
LANDRY M, FONSECA S, COHEN S, BOGUE C. Fatal enterovirus type 71 infection. The Pediatric Infectious Disease Journal 1995, 14: 1095-1100. PMID: 8745025, DOI: 10.1097/00006454-199512000-00013.Peer-Reviewed Original Research
1993
Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease
Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. Journal Of Clinical Microbiology 1993, 31: 2851-2856. PMID: 8263166, PMCID: PMC266143, DOI: 10.1128/jcm.31.11.2851-2856.1993.Peer-Reviewed Original ResearchConceptsCMV antigenemiaCentrifugation cultureClinical diseaseCMV antigensBlood samplesConventional cultureDetection of cytomegalovirusQuantitative cytomegalovirus antigenemiaHuman immunodeficiency virus-infected patientsBone marrow transplant recipientsCMV antigenemia testHigh-level antigenemiaVirus-infected patientsMarrow transplant recipientsDetection of antigenemiaCulture methodUse of immunofluorescenceAntigenemia testTransplant recipientsCMV infectionCytomegalovirus antigenemiaAntigenemiaIndividual patientsImmunoperoxidase stainingRapid diagnosis